JUUL LABS INC
ML
The past 12 months
Clients
1
past 12 months
Filings
1
past 12 months
Agencies contacted
Food & Drug Administration (FDA)HOUSE OF REPRESENTATIVESHealth & Human Services, Dept of (HHS)SENATE
Specific issues
-Risk-proportionate regulation for electronic delivery system products to advance tobacco harm reduction for adult smokers and policies to combat underage use. Issues related to enforcement of illicit tobacco products, including importation of illicit products. Issues related to taxation and user fees for tobacco and electronic nicotine delivery system products. Discussions related to implementation of Public Law 111-31, the Family Smoking Prevention and Tobacco Control Act, and PMTA submissions for deemed tobacco products.
H.R.4121/S.2256, Agriculture, Rural Development, FDA, and related Agencies Appropriations Act, FY 2026; provisions related to the regulation of tobacco and electronic nicotine delivery systems products, including enforcement against illicit products. H.R.5342/S.2354, Commerce, Justice, Science, and Related Agencies Appropriations Act, FY 2025; provisions related to the regulation of tobacco and electronic nicotine delivery system products, including enforcement against illicit products.
Clients
Sources
This profile is built from the public record: filings in the U.S. Senate Lobbying Disclosure Act system. lda.senate.gov ↗
Recent filings1
lda.gov →